We then had to increase that patent length in order to be in accordance with the wto. And that meant that pharmaceutical companies held onto their patents longer. Drugs could not go generic. That meant that it drove up costs on health care systems in the entire world. in order to more benefit the bottom line of pharmaceutical companies or in other types of tariff agreements that you can't discriminate and you can't have laws against financial institutions that have multiple services. (30:56–31:03)
CLAIM
Asserts that longer patent lengths increased global healthcare costs.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
